中文版dizal pharmaceutical 
biotech focusing on world leading r&d to solve unmet medical needs
Mei Wang
team leaderFreenome, Inc. 
Liquid biopsy blood test for early detection of cancers
Dr. Chuanbo Xu
Senior Director, Clinical DevelopmentGCV Life 
Life science-focused Innovation licensing organizations looking to commercialize global innovations for the Indian and South Asian markets through a unique partnership-led model.
Dr. Chirag Jain
AnalystHanhai Biolabs, Inc.
Cross border life science accelerator and angel investor based in San Francisco Bay Area and Wuxi, China.
Dr. Alex Zhang
CEOHumanwell Healthcare
Humanwell is the market leader in anaesthetics/analgesics, fertility regulation drugs, and Uyghur medicine in Asia. It is also a major player with expanding product portfolio and market shares in treating central nerve system, respiratory and dermatological diseases in China.
Mr. Zhehang DENG
Executive AssistantRoby Chen
投资部经理InnoCare
InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.
Jasmine Cui
CEOChunhua Lu
Head of CommunicationInnovation Forum 
The Innovation Forum is an accelerator for healthcare ventures. It is supported by a global grassroots network of over 10,000 innovators who seek to improve human health and wellbeing by translating cutting-edge science into innovative products and services. We focus on the future and the evolution of today’s technologies, which range from the nascent stage to the cusp of commercial application.
Responsive Web Design powered by 